These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22872803)

  • 21. Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era.
    Ling H; Lou X; Luo Q; He Z; Sun M; Sun J
    Acta Pharm Sin B; 2022 Dec; 12(12):4348-4364. PubMed ID: 36561998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophage therapy for human musculoskeletal and skin/soft tissue infections.
    Metsemakers WJ; Onsea J; Moriarty TF; Pruidze N; Nadareishvili L; Dadiani M; Kutateladze M
    Clin Microbiol Infect; 2023 Jun; 29(6):695-701. PubMed ID: 36669559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriophage therapeutics to confront multidrug-resistant Acinetobacter baumannii - a global health menace.
    Rai S; Kumar A
    Environ Microbiol Rep; 2022 Jun; 14(3):347-364. PubMed ID: 34196126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic Interactions among
    Lauman P; Dennis JJ
    Microbiol Spectr; 2023 Jun; 11(3):e0443022. PubMed ID: 37195168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparison of lytic activity of isolated phage and commercial Intesti bacteriophage on ESBL producer E. coli and determination of Ec_P6 phage efficacy with in vivo Galleria mellonella larvae model.
    Erol HB; Kaskatepe B; Ozturk S; Safi Oz Z
    Microb Pathog; 2022 Jun; 167():105563. PubMed ID: 35513294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriophage steering of
    Ruest MK; Supina BSI; Dennis JJ
    J Bacteriol; 2023 Oct; 205(10):e0019623. PubMed ID: 37791751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage Production in Compliance with Regulatory Requirements.
    Pirnay JP; Merabishvili M; De Vos D; Verbeken G
    Methods Mol Biol; 2024; 2734():89-115. PubMed ID: 38066364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance.
    Subramanian A
    Front Microbiol; 2024; 15():1384164. PubMed ID: 39035437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for Bacteriophage Product Certification.
    Fauconnier A
    Methods Mol Biol; 2018; 1693():253-268. PubMed ID: 29119445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growing Trend of Fighting Infections in Aquaculture Environment-Opportunities and Challenges of Phage Therapy.
    Kowalska JD; Kazimierczak J; Sowińska PM; Wójcik EA; Siwicki AK; Dastych J
    Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32512805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophage as an antibacterial agent: a patent perspective.
    Pathak-Vaidya P; Sharma S; Telang M
    Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage therapy: awakening a sleeping giant.
    Roach DR; Debarbieux L
    Emerg Top Life Sci; 2017 Apr; 1(1):93-103. PubMed ID: 33525818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria.
    Hasan M; Ahn J
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
    Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
    Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.
    Lin DM; Koskella B; Lin HC
    World J Gastrointest Pharmacol Ther; 2017 Aug; 8(3):162-173. PubMed ID: 28828194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.